Author
Listed:
- SJ Yu
(Department of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University, Gwangjin-gu, Seoul, Republic of Korea)
- HE Kim
(Department of Veterinary Internal Medicine, Konkuk University Veterinary Medical Teaching Hospital, Gwangjin-gu, Seoul, Republic of Korea)
- HJ Han
(Veterinary Emergency Medicine and Critical Care, Konkuk University Veterinary Medical Teaching Hospital, Gwangjin-gu, Seoul, Republic of Korea)
- JH Kim
(Department of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University, Gwangjin-gu, Seoul, Republic of Korea)
Abstract
A 2-year-old, castrated, male Russian blue cat presented with acute dyspnoea, cyanosis, and lethargy. A thoracic radiography revealed a large cranial mediastinal mass; the computed tomography revealed caudal lobe atelectasis of the right lung with pericardial and pleural effusions. The cytodiagnostic tests revealed high-grade CD4+ CD8+ T-cell mediastinal lymphoma as clinical stage Vb; l-asparaginase-cyclophosphamide-doxorubicin-vincristine-prednisolone (l-CHOP)-based chemotherapy was initiated, following which the mass shrunk rapidly; 1 week after the initiation of chemotherapy, the appetite-related and respiratory symptoms improved dramatically, and the pleural and pericardial effusion resolved. The patient remains in complete remission three years after the initiation of the l-CHOP chemotherapy. Therefore, the accurate diagnosis and instantaneous initiation of chemotherapy may resolve life-threatening pleural and pericardial effusions in cats with high-grade aberrant T-cell mediastinal lymphoma.
Suggested Citation
SJ Yu & HE Kim & HJ Han & JH Kim, 2022.
"Successful management of feline CD4+ CD8+ T-cell mediastinal lymphoma with pericardial effusion,"
Veterinární medicína, Czech Academy of Agricultural Sciences, vol. 67(10), pages 544-551.
Handle:
RePEc:caa:jnlvet:v:67:y:2022:i:10:id:70-2021-vetmed
DOI: 10.17221/70/2021-VETMED
Download full text from publisher
As the access to this document is restricted, you may want to
for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:caa:jnlvet:v:67:y:2022:i:10:id:70-2021-vetmed. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Ivo Andrle (email available below). General contact details of provider: https://www.cazv.cz/en/home/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.